Clinical Trial Update: Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study [Phase 2]

View source ↗

Summary

A Phase 2 cohort study evaluating the safety and efficacy of radiation therapy given during Osimertinib treatment in patients with EGFR-positive non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TAGRISSO (osimertinib)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: NSCLC, EGFR Positive Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING